A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-0122
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2008
Authors
Publisher
American Association for Cancer Research (AACR)